The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis.
about
Anti-cytokine therapies for primary systemic necrotizing vasculitisExploration, Development, and Validation of Patient-reported Outcomes in Antineutrophil Cytoplasmic Antibody-associated Vasculitis Using the OMERACT ProcessPatient-Reported Outcomes in Glomerular Disease.Involving patient research partners has a significant impact on outcomes research: a responsive evaluation of the international OMERACT conferencesDamage in the anca-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials.Assessment of health-related quality of life as an outcome measure in granulomatosis with polyangiitis (Wegener's).Mapping of the outcome measures in rheumatology core set for antineutrophil cytoplasmic antibody-associated vasculitis to the International Classification of Function, Disability and HealthCurrent status of outcome measure development in vasculitis.Outcome measures used in clinical trials for Behçet syndrome: a systematic review.Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agenda.The Birmingham Vasculitis Activity Score as a Measure of Disease Activity in Patients with Giant Cell Arteritis.Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials.Granulomatosis with polyangiitis in childhood.Towards the harmonization of outcome measures in children with mitochondrial disorders.Disease assessment in systemic vasculitis.Patient-reported outcomes in core domain sets for rheumatic diseases.Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS).OMERACT Endorsement of Patient-reported Outcome Instruments in Antineutrophil Cytoplasmic Antibody-associated Vasculitis.Clinicians' perspective on key domains in ANCA-associated vasculitis: a Delphi exercise.Vasculitis syndromes: Vasculitis assessments--what do patients think?Patient and physician perspectives on the impact of health-related quality of life in Mexican patients with ANCA-associated vasculitis.Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure.The role of pain, perseverative cognition and goal adjustment in vasculitis-associated fatigue.Issues in trial design for ANCA-associated and large-vessel vasculitis.Rasch analysis suggests that health assessment questionnaire II is a generic measure of physical functioning for rheumatic diseases: a cross-sectional study.
P2860
Q24241555-D81DC3E8-2F5B-4DC2-987E-C3F41F96C01DQ26795465-B909853F-D3FC-4D03-9466-8CEC2585233AQ30249861-0EBD5AB5-C061-41DB-BAA6-03B210F4303EQ30539740-33494C63-1A50-416C-8AF2-050CDF515FE9Q30696868-FC1D4EA0-8919-4ADE-9A79-311BB4F8B271Q35649141-15D4FFB5-CAF2-48C7-AEB2-B30A135131E1Q35861668-7E054946-DFDA-4B7B-BD99-05BC5E0F42E7Q35865798-BD00C2D3-0906-41E3-861A-5F2BEEC4760DQ35868282-83998BA9-56C5-43BB-805A-652B41060B3CQ36843077-551555D4-5ED7-440B-B65B-A7CE95320A1EQ36963349-169C7AE7-39AF-4755-9921-E31F9B32E0FFQ37926278-C2B4B12D-CB69-4179-8A42-979D8EEC5A2AQ37979678-18550E05-593B-4214-9B2F-74F9C730DB96Q38089161-168F0602-00C1-4151-8BC0-C62DE7AB7B83Q38348251-A95874D0-3CFE-4B30-AB1F-76A91CFDD437Q38577796-C20D82A2-1836-46BA-A7A9-FF02670937A8Q39530208-BA5E5608-C3CF-4F2B-9C5D-84FE7681B327Q40060881-B5B9C8EB-3D81-4965-8A7C-EBDDBBB6F8E3Q40641846-01391566-4FC9-48AD-B841-BC48A37C1224Q46718009-A5BCDF40-5CF1-4ECE-990F-AE2F50146D49Q47299381-53B42530-6D1B-40E3-996D-9A3726D616F7Q47552107-1DD82F41-5278-46E1-B236-8830784A95FFQ47846567-09E4C01D-6ECD-41A3-A6DD-44776B034FCAQ48937679-A5877888-B5B3-4CC5-BFA4-28C249B0BF77Q55241374-31B247F5-701D-4032-BF30-23E29E632009
P2860
The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
The OMERACT core set of outcom ...... of ANCA-associated vasculitis.
@en
type
label
The OMERACT core set of outcom ...... of ANCA-associated vasculitis.
@en
prefLabel
The OMERACT core set of outcom ...... of ANCA-associated vasculitis.
@en
P2093
P2860
P356
P1476
The OMERACT core set of outcom ...... of ANCA-associated vasculitis
@en
P2093
Gunnar Tomasson
Haner Direskeneli
Karen Herlyn
Maarten Boers
Peter A Merkel
Ravi Suppiah
Sibel Z Aydin
P2860
P304
P356
10.3899/JRHEUM.110276
P407
P577
2011-07-01T00:00:00Z